Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaillie Geu Regulatory News (BGEU)

Share Price Information for Baillie Geu (BGEU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 96.10
Bid: 95.90
Ask: 96.60
Change: 1.00 (1.05%)
Spread: 0.70 (0.73%)
Open: 95.30
High: 96.10
Low: 95.00
Prev. Close: 95.10
BGEU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

18 Jan 2024 14:20

RNS Number : 1958A
Baillie Gifford European Growth Tst
18 January 2024

Baillie Gifford European Growth Trust plc (BGEU)

Legal Entity Identifier: 213800QNN9EHZ4SC1R12

Results of Annual General Meeting

At the Annual General Meeting ('AGM') held on 18 January 2024 shareholders approved the following resolutions:

Ordinary Resolutions

1. To receive and adopt the Financial Statements of the Company for the year to 30 September 2023 with the Reports of the Directors and of the Independent Auditor thereon.

2. To approve the Directors' Annual Report on Remuneration for the year to 30 September 2023.

3. To declare a final dividend of 0.40p per ordinary share.

4. To elect David Barron as a Director of the Company.

5. To re-elect Michael MacPhee as a Director of the Company.

6. To re-elect Andrew Watkins as a Director of the Company.

7. To re-elect Emma Davies as a Director of the Company.

8. To re-appoint BDO LLP as Independent Auditor of the Company to hold office from the conclusion of this meeting until the conclusion of the next Annual General Meeting at which the Financial Statements are laid before the Company.

9. To authorise the Directors to determine the remuneration of the Independent Auditor of the Company.

10. That, in substitution for any existing authority, but without prejudice to the exercise of any such authority prior to the date hereof, the Directors of the Company be and they are hereby generally and unconditionally authorised in accordance with section 551 of the Companies Act 2006 (the 'Act') to exercise all the powers of the Company to allot shares in the Company and to grant rights to subscribe for or to convert any security into shares in the Company ('Securities') provided that such authority shall be limited to the allotment of shares and the grant of rights in respect of shares with an aggregate nominal value of up to £2,983,249, such authority to expire at the conclusion of the next Annual General Meeting of the Company after the passing of this resolution or on the expiry of 15 months from the passing of this resolution, whichever is the earlier, unless previously revoked, varied or extended by the Company in a general meeting, save that the Company may at any time prior to the expiry of this authority make an offer or enter into an agreement which would or might require Securities to be allotted or granted after the expiry of such authority and the Directors shall be entitled to allot or grant Securities in pursuance of such an offer or agreement as if such authority had not expired.

Special Resolutions

11. That, subject to the passing of Resolution 10 above, and in substitution for any existing power but without prejudice to the exercise of any such power prior to the date hereof, the Directors of the Company be and they are hereby generally empowered, pursuant to sections 570 and 573 of the Companies Act 2006 (the 'Act'), to allot equity securities (within the meaning of section 560(1) of the Act), for cash pursuant to the authority given by Resolution 10 above, and to sell treasury shares for cash, as if section 561(1) of the Act did not apply to any such allotment or sale, provided that this power:

a) expires at the conclusion of the next Annual General Meeting of the Company after the passing of this Resolution or on the expiry of 15 months from the passing of this Resolution, whichever is the earlier, save that the Company may, before such expiry, make an offer or agreement which would or might require equity securities to be allotted or treasury shares to be sold after such expiry and the Directors may allot equity securities or sell treasury shares in pursuance of any such offer or agreement as if the power conferred hereby had not expired; and

b) shall be limited to the allotment of equity securities or the sale of treasury shares up to an aggregate nominal value of £894,974, being approximately 10% of the nominal value of the issued share capital of the Company, as at 15 November 2023.

12. That, in substitution for any existing authority but without prejudice to the exercise of any such authority prior to the date hereof, the Company be and is hereby generally and unconditionally authorised, pursuant to and in accordance with section 701 of the Companies Act 2006 (the 'Act') to make market purchases (within the meaning of section 693(4) of the Act) of fully paid ordinary shares of 2.5 pence each in the capital of the Company ('ordinary shares') (either for retention as treasury shares for future reissue, resale, transfer or cancellation), provided that:

a) the maximum aggregate number of ordinary shares hereby authorised to be purchased is 53,662,686, or, if less, the number representing approximately 14.99% of the issued ordinary share capital of the Company as at the date of the passing of this Resolution;

b) the minimum price (excluding expenses) which may be paid for each ordinary share shall be the nominal value of that share;

c) the maximum price (excluding expenses) which may be paid for each ordinary share shall not be more than the higher of:

i. 5 per cent above the average closing price on the London Stock Exchange of an ordinary share over the five business days immediately preceding the date of purchase; and

ii. the higher of the last independent trade and the highest current independent bid on the London Stock Exchange; and

d) unless previously varied, revoked or renewed by the Company in a general meeting, the authority hereby conferred shall expire at the conclusion of the Annual General Meeting of the Company to be held in respect of the year ending 30 September 2024, save that the Company may, prior to such expiry, enter into a contract to purchase ordinary shares under such authority which will or might be completed or executed wholly or partly after the expiration of such authority and may make a purchase of ordinary shares pursuant to any such contract.

13. That, the Company be and is hereby generally and unconditionally authorised to hold general meetings (other than Annual General Meetings) on 14 clear days' notice, such authority to expire at the conclusion of the next Annual General Meeting of the Company.

Resolutions 1 to 13 were passed on a poll. A breakdown of the votes registered is shown below:

Resolution

Votes for (including votes at the discretion of the Chairman)

%

Votes Against

%

Votes Withheld

Ordinary Resolutions

1

146,307,947

99.99

19,285

0.01

78,741

2

145,621,496

99.67

488,727

0.33

295,750

3

146,347,461

99.99

17,243

0.01

52,369

4

146,026,847

99.91

126,787

0.09

263,439

5

113,718,679

97.56

2,854,274

2.44

29,853,119

6

143,403,533

98.11

2,762,722

1.89

250,817

7

143,989,929

98.49

2,206,636

1.51

220,507

8

146,144,759

99.93

100,023

0.07

172,291

9

146,195,721

99.96

60,639

0.04

160,713

10

146,061,920

99.90

151,495

0.10

203,658

Special Resolutions

11

145,882,801

99.67

480,449

0.33

53,823

12

140,745,606

96.15

5,628,628

3.85

42,839

13

145,791,031

99.61

575,786

0.39

50,256

Baillie Gifford & Co Limited

Company Secretaries

18 January 2024

Regulated Information Classification: Additional regulated information required to be disclosed under applicable laws

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGSFAFLAELSEFF
Date   Source Headline
3rd May 202411:53 amRNSNet Asset Value(s)
2nd May 202411:22 amRNSNet Asset Value(s)
1st May 20243:28 pmRNSNet Asset Value(s)
1st May 202410:45 amRNSTotal Voting Rights
30th Apr 20245:13 pmRNSTransaction in Own Shares
30th Apr 202412:01 pmRNSNet Asset Value(s)
29th Apr 202412:12 pmRNSNet Asset Value(s)
26th Apr 20244:51 pmRNSTransaction in Own Shares
26th Apr 202411:54 amRNSNet Asset Value(s)
25th Apr 202411:34 amRNSNet Asset Value(s)
24th Apr 202412:40 pmRNSNet Asset Value(s)
23rd Apr 20244:45 pmRNSTransaction in Own Shares
23rd Apr 202411:56 amRNSNet Asset Value(s)
22nd Apr 202412:20 pmRNSNet Asset Value(s)
19th Apr 20243:41 pmRNSDirector/PDMR Shareholding
19th Apr 20241:24 pmRNSNet Asset Value(s)
18th Apr 202411:26 amRNSNet Asset Value(s)
17th Apr 20244:59 pmRNSTransaction in Own Shares
17th Apr 202412:10 pmRNSNet Asset Value(s)
16th Apr 20244:05 pmRNSNet Asset Value(s)
15th Apr 202412:07 pmRNSNet Asset Value(s)
12th Apr 20244:57 pmRNSTransaction in Own Shares
12th Apr 202411:37 amRNSNet Asset Value(s)
11th Apr 20245:13 pmRNSTransaction in Own Shares
11th Apr 202411:12 amRNSNet Asset Value(s)
10th Apr 202412:06 pmRNSNet Asset Value(s)
9th Apr 20245:12 pmRNSTransaction in Own Shares
9th Apr 202411:23 amRNSNet Asset Value(s)
8th Apr 202411:06 amRNSNet Asset Value(s)
5th Apr 202411:47 amRNSNet Asset Value(s)
4th Apr 202411:21 amRNSNet Asset Value(s)
3rd Apr 20245:25 pmRNSTransaction in Own Shares
3rd Apr 202411:17 amRNSNet Asset Value(s)
2nd Apr 20245:14 pmRNSClosed Period Confirmation
2nd Apr 20244:31 pmRNSNet Asset Value(s)
2nd Apr 20243:58 pmRNSNet Asset Value(s)
2nd Apr 20242:54 pmRNSTotal Voting Rights
2nd Apr 20241:41 pmRNSNet Asset Value(s)
28th Mar 20244:53 pmRNSTransaction in Own Shares
28th Mar 202411:45 amRNSNet Asset Value(s)
27th Mar 202411:53 amRNSNet Asset Value(s)
26th Mar 20244:56 pmRNSTransaction in Own Shares
26th Mar 202411:38 amRNSNet Asset Value(s)
25th Mar 202412:20 pmRNSNet Asset Value(s)
22nd Mar 202412:06 pmRNSNet Asset Value(s)
21st Mar 202411:51 amRNSNet Asset Value(s)
20th Mar 20245:46 pmRNSTransaction in Own Shares
20th Mar 202412:12 pmRNSNet Asset Value(s)
19th Mar 20242:24 pmRNSHolding(s) in Company
19th Mar 202412:28 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.